Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,106 Gastrointestinal
clinical trials

Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Center for Wound Healing Crozer Chester Medical Center
mi
from
Chester, PA
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Beverly Hospital Wound and Hyperbaric Center
mi
from
Montebello, CA
Click here to add this to my saved trials
Venous Leg Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Venous Leg Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
St Joseph Mercy Oakland Hospital Center for Wound Care and Hyperbaric Medicine
mi
from
Pontiac, MI
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Center for Wound Healing at FHN
mi
from
Freeport, IL
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Catskill Regional Medical Center - Wound Healing Center
mi
from
Harris, NY
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Memorial Hermann South East
mi
from
Houston, TX
Click here to add this to my saved trials
Pressure Ulcer Clinical Trial
Effectiveness of Aurix Therapy in Pressure Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Aria Health Frankford Wound Care Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Methodist Hospital Wound Care Center
mi
from
Arcadia, CA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Memorial Hermann Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
St. Mary's Wound and Hyperbaric Center
mi
from
Huntington, WV
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Orange Regional
mi
from
Middletown, NY
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Kaweah Delta Rehabiliation Hospital
mi
from
Visalia, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Consultants for Clinical Research Inc.; Cornell Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
West Central Gastroenterology d/b/a Gastro Florida
mi
from
Clearwater, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
GastroCare
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trials of North Carolina, LLC
mi
from
Durham, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor Gastroenterology Assoc
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Orange County Institute of Gastroenterology & Endoscopy
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Disease Specialists
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Washington / Harborview Medical Center; University of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
The iResearch Group, LLC
mi
from
Southfield, MI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
Status: Enrolling, Phase III
Updated: 12/31/1969
DBC Research, Corp
mi
from
Tamarac, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Evanston, IL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hagerstown, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Hollywood, MD
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Humble, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Kinston, NC
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Palm Harbor, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Sherwood, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Shreveport, LA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Bristol, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Great Neck, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Reno, NV
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
One Year Study of Rifaximin Delayed Release (DR) Tablets in Crohn's Disease
Status: Enrolling, Phase III
Updated: 4/26/2017
Clinical Research Facility
mi
from
Urbana, IL
Click here to add this to my saved trials
Acute Hepatic Porphyria Clinical Trial
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Trial Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Gastroparesis Clinical Trial
The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
Status: Enrolling, Phase II
Updated: 12/12/2016
Spring Family Clinic
mi
from
Spring, TX
Click here to add this to my saved trials
Gastroenterology, Neurology, Rheumatology Clinical Trial
The Colonic Microbiome and Mucosal Immunity in Inflammatory Bowel Disease and Ankylosing Spondylitis
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Columbia, MD
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Egg Harbor, NJ
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Lone Tree, CO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy of GS-5745 in Adults With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling, Phase II, III
Updated: 5/2/2016
Clinical Research Facility
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Liver Center of Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
VA Medical Center Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Indiana University (IU) Health University Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Vanderbilt University Medical Center - Digestive Disease Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovative Clinical Research
mi
from
Rapid City, SD
Click here to add this to my saved trials
Non Alcoholic Steatohepatitis (NASH) Clinical Trial
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California San Francisco (UCSF) / San Francisco General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Health Clinical Trials Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Innovative Clinical Research
mi
from
Greenville, SC
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Regenerate Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Moore Clinical Trials, LLC
mi
from
Sherwood, AR
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
Status: Enrolling, Phase III
Updated: 12/31/1969
Allied Gastrointestinal Associates, PA
mi
from
Voorhees, NJ
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Professionals, LLC - De Paul Medical Dr
mi
from
Bridgeton, MO
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Hospital Italiano
mi
from
Buenos Aires,
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas HealthCare System Digestive Health
mi
from
Charlotte, NC
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
UC Health Clinical Trials Office
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Aurora Care Clinic
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Universal Axon Clinical Research, LLC
mi
from
Doral, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Regenerate Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Facey Medical Foundation (Parent)
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
NSB Research
mi
from
New Smyrna Beach, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
DM Clinical Research
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Theia Clinical Research
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
San Antonio Gastroenterology
mi
from
San Antonio, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Digestive Disease Consultants - Southlake
mi
from
Southlake, TX
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Virginia; Gastroenterology and Hepatology
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clin. Rsrch Inst. of Michigan
mi
from
Chesterfield, MI
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
GastroCare; Digestive Care Research
mi
from
Coral Springs, FL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Iowa Digestive Disease Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Valley Gastroenterology Cnslts
mi
from
Glendora, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Long Island Clin Rsch Asc, LLP
mi
from
Great Neck, NY
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Mississippi Medical Center; Division of Gastroenterology
mi
from
Jackson, MS
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Gastroenterology; DM Clinical Research
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Digestive Care Associates, A Medical Corporation
mi
from
San Carlos, CA
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
AGA Clinical Research Associates, LLC
mi
from
Twp, NJ
Click here to add this to my saved trials
Crohn Disease Clinical Trial
A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants With Moderately to Severely Active Crohn's Disease (CD)
Status: Enrolling, Phase III
Updated: 12/31/1969
ABS Health, LLC
mi
from
Whittier, CA
Click here to add this to my saved trials
1 … 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 … 101